Secondary Lymphedema

in Lymphedema

Applied

Type

Addition

Confidence

90%

Created

Mar 20, 2026

Evidence

3 sources

Rationale

The integration incorporates high-level evidence (meta-analyses and systematic reviews) from 2025 and 2026. It expands the 'Cancer-related' section to include the importance of early prevention and the impact of socioeconomic disparities, which are critical modern considerations in vascular and oncologic care. It also reinforces the role of physical therapy in the management of secondary lymphedema. Abbreviations were expanded on first use as required.

Evidence

Wu Y et al. Effects of Early Preventive Interventions on Breast Cancer-Related Lymphedema: A Meta-Analysis and Systematic Review. Cancer Nursing. 2026. PMID: 41817405.
Verified source
PubMedDOI
Mattia A et al. Disparities in Breast Cancer-related Lymphedema: A Systematic Review of Inequities and Barriers in Care. Plastic and Reconstructive Surgery - Global Open. 2025. PMID: 40606803.
Verified source
PubMedDOI
Aguilera-Eguía RA et al. Which Physical Therapy Intervention Is Most Effective in Reducing Secondary Lymphedema Associated with Breast Cancer? A Systematic Review and Network Meta-Analysis. Journal of Clinical Medicine. 2025. PMID: 41095841.
Verified source
PubMedDOI

Content Changes

<!-- type: risk-factors -->

* **Cancer-related:** most common cause in developed countries.
  + Breast cancercancer-related lymphedema (BCRL) (axillary lymph node dissection, radiation).radiation); early preventive interventions are critical in reducing incidence [@wu2026].
  + Gynecologic malignancies (pelvic node dissection).
  + Prostate and urologic cancers.
  + Socioeconomic disparities and barriers to care significantly influence the prevalence and severity of BCRL [@mattia2025].
* **Infectious:**
  + Filariasis (*Wuchereria bancrofti*) – leading global cause.
* **Other:**
  + Trauma, chronic venous diseaseinsufficiency (CVI) (see [[CVI]]), obesity, inflammatory conditions.
  + Physical therapy remains a primary intervention for managing secondary lymphedema associated with breast cancer [@which2025].
Go to section in textbookDispute / Submit evidenceAll updates